Sponsored Links
The Cancer Project
Nutrition and Diet Resource for Cancer Prevention and Survival
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
Press Release | www.prnewswire.com | 9 hours 47 minutes ago
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting.
Bowel cancer drug rejected for NHS
News | www.channel4.com | 15 hours 23 minutes ago
The drug Avastin, which could extend the lives of bowel cancer sufferers by up to two years, has been rejected by the governments watchdog amid fears of spiralling NHS costs. Jenny Wivell reports. The drug Avastin, which could extend the lives of bowel cancer sufferers by up
http://www.channel4.com/news/articles/science_technology/bowel+cancer+drug+rejected+for+nhs/3436017
How Millennium Is Tapping A Harvard Lab to Help Discover New Cancer Drugs
News | www.xconomy.com | 21 hours 16 minutes ago
When Deborah Dunsire, CEO of Millennium: The Takeda Oncology Company, talked about what makes the Boston area an attractive place to do business at a recent
NICE again rejects Roche bowel cancer drug
News | uk.reuters.com | Nov 24, 2009
LONDON (Reuters) - Britain's healthcare cost-effectiveness watchdog has again rejected Roche's drug Avastin as a treatment for bowel cancer, saying it is too expensive. The National Institute for Health
Another cancer drug too dear for Britain: How bowel cancer victims are denied life-prolonging drug that's free in Europe
News | www.dailymail.co.uk | Nov 24, 2009
In what has been dubbed 'passport prescribing', Britain does not allow routine use of the drug Avastin while patients in virtually all other EU countries get the drug paid for. In what has been dubbed 'passport prescribing', Britain does not allow routine use of the drug Avastin while patients in
Leukaemia breakthrough as Irish researchers find drug with fewer side effects
News | www.telegraph.co.uk | Nov 23, 2009
Irish medical researchers claimed today they a significant step in improving treatments for leukaemia after encouraging results from tests on a new drug.
Astex Therapeutics gains orphan approval in US and Europe
News | www.businessweekly.co.uk | Nov 23, 2009
Astex Therapeutics, fresh from a multi-million pound deal with GSK, has announced that it has been granted orphan drug designation in Europe and the US for its treatment of patients with Acute Myeloid Leukaemia (AML).
TapImmune, Inc. to be Featured in Small Cap Stock Newsletter QualityStocks Daily - Zibb.com
Press Release | www.zibb.com | Nov 23, 2009
TapImmune, Inc. (OTCBB:TPIV) announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap
Mammogram guidelines spark debate over health bill
News | www.newsvine.com | Nov 22, 2009
Lawmakers broke along party lines on a new aspect of the health care debate Sunday as a former National Institutes of Health chief urged women to ignore guidelines that delay the start of breast cancer screenings.
http://www.newsvine.com/_news/2009/11/22/3530966-mammogram-guidelines-spark-debate-over-health-bill
Home-furnishings maker triples space
News | www.crainsnewyork.com | Nov 22, 2009
jla home, which manufactures home furnishings and bedding products, has expanded its showroom and office space and will occupy a total of 36,200 square feet of space in Manhattan.
http://www.crainsnewyork.com/article/20091122/HOLD/311229966
